Here are 10 things to know about the public offering:
1. The company gave a public price of $1.14 per unit for more than 11.4 million units.
2. Total gross proceeds are expected at around $13 million before deducting underwriting discounts and commissions and estimated offering expenses.
3. Each unit is one share of Amedica common stock and one warrant to purchase one share of common stock.
4. The warrants have an excise price of $1.48 and can be exercised on a cashless basis.
5. The warrants will expire within five years of the issuance date.
6. Amedica granted underwriters a 45-day option to purchase up to 1,716,246 additional shares of common stock and the same number of additional warrants, or any combination thereof, solely to cover over-allotments, if any.
7. The offering is expected to close on or about Nov. 26, 2014.
8. Dawson James Securities is acting as the sole book-running manager for the offering.
9. Amedica is offering the securities pursuant to a registration statement on Form S-1 that was declared effective on Nov. 20 by the SEC.
10. Copies of the final prospectus from the offering can be obtained from Dawson James Securities.
More articles on orthopedic devices:
Investor notes: 6 spine device company updates
Aurora Spine gets FDA clearance on new device
Will Integra LifeScience’s new spine product be enough to sustain growth before SeaSpine spin-off?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
